Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Short-Term Debt repayments (2017 - 2025)

Myriad Genetics (MYGN) has disclosed Short-Term Debt repayments for 7 consecutive years, with $60.0 million as the latest value for Q3 2025.

  • Quarterly Short-Term Debt repayments rose 200.0% to $60.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $80.5 million through Dec 2025, down 32.64% year-over-year, with the annual reading at $80.5 million for FY2025, 32.64% down from the prior year.
  • Short-Term Debt repayments for Q3 2025 was $60.0 million at Myriad Genetics, up from $20.5 million in the prior quarter.
  • The five-year high for Short-Term Debt repayments was $106.4 million in Q3 2021, with the low at $19.5 million in Q4 2024.
  • Average Short-Term Debt repayments over 4 years is $46.6 million, with a median of $45.0 million recorded in 2021.
  • Peak annual rise in Short-Term Debt repayments hit 200.0% in 2025, while the deepest fall reached 65.83% in 2025.
  • Over 4 years, Short-Term Debt repayments stood at $106.4 million in 2021, then plummeted by 62.41% to $40.0 million in 2023, then tumbled by 51.25% to $19.5 million in 2024, then surged by 207.69% to $60.0 million in 2025.
  • According to Business Quant data, Short-Term Debt repayments over the past three periods came in at $60.0 million, $20.5 million, and $19.5 million for Q3 2025, Q1 2025, and Q4 2024 respectively.